Multiple Sclerosis and Related Disorders: review time and acceptance speed
ISSN 2211-0348 · ISSN 2211-0356 · Elsevier BV · Medicine
Half of the articles Multiple Sclerosis and Related Disorders accepted in 2025 were accepted within 116 days of submission (n = 518); the middle half took 74–183 days.
Accepted articles only · dates deposited by the publisher in PubMed · data as of Sep 15, 2026
How long does Multiple Sclerosis and Related Disorders take to accept a paper?
| Year | Articles (n) | 25th pct | Median | 75th pct | 90th pct | Accepted <14 days | Have a revised date |
|---|---|---|---|---|---|---|---|
| 2025 | 518 | 74 | 116 | 183 | 286 | 2.1% | 94% |
| 2024 | 457 | 87 | 128 | 181 | 250 | 0.9% | 96% |
| 2023 | 494 | 76 | 111 | 157 | 211 | 1.6% | 94% |
| 2022 | 580 | 58 | 92 | 141 | 200 | 3.5% | 95% |
| 2021 | 534 | 52 | 88 | 133 | 183 | 2.1% | 94% |
| 2020 | 566 | 49 | 77 | 122 | 173 | 5.8% | 95% |
- 2026: not shown yet — a year is reported once late-indexed articles have arrived (at least 180 days after it ends).
Research articles vs reviews (2025)
| Type | n | 25th pct | Median | 75th pct |
|---|---|---|---|---|
| Research articles | 418 | 75 | 117 | 186 |
| Reviews | 98 | 72 | 113 | 163 |
Distribution in 2025
Show as a table
| Days | Articles | Share |
|---|---|---|
| 0–29 | 25 | 4.8% |
| 30–59 | 64 | 12.4% |
| 60–89 | 76 | 14.7% |
| 90–119 | 109 | 21.0% |
| 120–149 | 67 | 12.9% |
| 150–179 | 42 | 8.1% |
| 180–209 | 30 | 5.8% |
| 210–239 | 16 | 3.1% |
| 240–269 | 22 | 4.2% |
| 270–299 | 24 | 4.6% |
| 300–329 | 13 | 2.5% |
| 330–359 | 9 | 1.7% |
| 360+ | 21 | 4.1% |
From acceptance to online publication
After acceptance, half of the 2025 articles appeared online within 1 day (middle half 1–2 days, n = 518).
From submission to online publication, the median was 119 days (middle half 76–187 days, n = 518).
Read these numbers carefully
- These times describe articles the journal accepted. Rejected manuscripts never appear in public data, so they cannot tell you how long a rejection takes.
- Dates are the ones the publisher deposited with PubMed. Some publishers record the date a revised manuscript arrived as the submission date, which makes review look faster.
- Invited articles and special issues can move faster than regular submissions.
Open access status and publishing fees
Hybrid (subscription journal with an open-access option). Listed APC: about $3,500 (as reported by OpenAlex).
OpenAPC has fewer than 5 reported payments for this journal in 2023–2025, so no typical amount is shown.
Many journals waive or reduce fees for authors from eligible countries or institutions with publishing agreements — check with the journal and your library.
Integrity and indexing signals
Facts from public records, shown without judgement. See the methodology for why each can be worth a closer look.
| Listed in DOAJ | No |
|---|---|
| Articles indexed for MEDLINE in 2025 | Yes |
| Retractions | 1 retracted article among 2,601 added to PubMed in 2021–2025 (0.38 per 1,000), per the Retraction Watch Database. |
| Accepted within 14 days of submission | 2.1% of 2025 articles |
| Publication volume | 517 articles added to PubMed in 2025 (+8% vs 2024). |
Topics and scope
- Multiple Sclerosis Research Studies (45% of indexed topics)
- Peripheral Neuropathies and Disorders (12% of indexed topics)
- Systemic Sclerosis and Related Diseases (4% of indexed topics)
- Polyomavirus and related diseases (4% of indexed topics)
- Amyotrophic Lateral Sclerosis Research (4% of indexed topics)
- Long-Term Effects of COVID-19 (4% of indexed topics)
Similar journals — faster or cheaper, side by side
Journals publishing on the most similar topics (OpenAlex), ordered by similarity. Only 2025 figures are compared with the 2025 median of Multiple Sclerosis and Related Disorders, 116 days.
| Paid APC median | DOAJ | MEDLINE | |||
|---|---|---|---|---|---|
| Multiple Sclerosis Journal - Experimental Translational and Clinical | 143 (2025, n = 67) | $2,650 | $1,768 (5 payments) | Yes | No |
| Therapeutic Advances in Neurological Disorders | 112 (2025, n = 128) | $2,650 | $2,267 (12 payments) | Yes | No |
| Neurology and Therapy | 56 (2025, n = 160) | $7,675 | — | Yes | No |
| Journal of Neuroimmunology | 107 (2025, n = 225) | ≈$3,360 | — | No | Yes |
| Annals of Clinical and Translational Neurology | 82 (2025, n = 316) | $4,100 | $3,094 (8 payments) | Yes | Yes |
| Journal of Neurology | 59 (2025, n = 617) | ≈$4,790 | — | No | Yes |
| European Journal of Neurology | 113 (2025, n = 363) | $3,960 | $3,532 (10 payments) | Yes | Yes |
| BMJ Neurology Open | 92 (2025, n = 113) | ≈$3,223 | $2,294 (6 payments) | Yes | No |
No journals match these filters.
Frequently asked questions
How long does Multiple Sclerosis and Related Disorders take to accept a paper?
Half of the articles Multiple Sclerosis and Related Disorders accepted in 2025 were accepted within 116 days of submission (n = 518); the middle half took 74–183 days. Based on dates in PubMed for accepted articles only.
How long after acceptance are Multiple Sclerosis and Related Disorders articles published online?
Half of the articles accepted in 2025 appeared online within 1 day of acceptance (n = 518).
Does Multiple Sclerosis and Related Disorders charge an article processing charge (APC)?
Listed APC: about $3,500 (as reported by OpenAlex).
Sources and method
Journal identity: ISSN-L 2211-0348; NLM ID 101580247; OpenAlex record. Speed figures use 518 articles accepted in 2025 with valid dates; excluded records for that year: none.
Spotted a problem with this journal's data, or are you the publisher? Report a correction or email rafiq@gradsummit.com. Verified errors are corrected within five business days.
Get the free Journal Submission Go/No-Go Checklist
The pre-submission checks from Write and Publish a Scientific Paper: journal fit, formatting, cover letter and reviewer suggestions. We’ll email you the download link.
Data sources. Submission, acceptance and publication dates: Courtesy of the U.S. National Library of Medicine (PubMed, entries through Sep 15, 2026). NLM does not endorse Journal Clock, and these figures may not reflect the most current PubMed data. Journal fees and open-access listing: DOAJ (CC0, retrieved Sep 16, 2026). Fees paid by institutions: OpenAPC (Open Database License, retrieved Sep 16, 2026). Retractions: Retraction Watch Database via Crossref (retrieved Sep 16, 2026). Journal identifiers and topics: OpenAlex (CC0). Currency conversion: ECB reference rates (Sep 15, 2026). How these numbers are calculated · For organisations.